ARNOLD & PORTER KAYE SCHOLER LLP

ARNOLD & PORTER KAYE SCHOLER LLP filed a registration for UNICYCIVE THERAPEUTICS INC. on October 5, 2026.

Lobbying for UNICYCIVE THERAPEUTICS INC. · Clinical-stage biopharmaceutical company focused on novel therapies for kidney disease.

All filings by ARNOLD & PORTER KAYE SCHOLER LLP · Everything UNICYCIVE THERAPEUTICS INC. has reported

Filing · LD-1 registration Registration

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 5, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

California

Official filing document

Lobbyists on this filing 2

BOBBY MCMILLIN New on this filing

Previously held: General Counsel, Senate Health, Education, Labor, & Pensions (HELP) Committee (2015-2019); Counsel, Senate HELP Committee (2015); Counsel, Sen. Chambliss (2013-2015); Regional Rep., Sen. Chambliss (2012-13); Press Intern, Sen. Chambliss (2007)
ROHITH CHARI New on this filing

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 1

Health Issues

Issue related to kidney disease therapeutics.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.